Editorial policy

Our mission

Kesho provides evidence-based GLP-1 education for Indian patients. We explain drug classes, clinical guidelines, safety, access, and nutrition, without promoting specific brands or prescribing medications.

Medical review

Content is authored and reviewed by qualified clinicians. Our primary medical reviewer is Dr. Ananya Mehta, MD, DM Endocrinology. Editorial standards reflect input from Endocrinologists, Internal Medicine Specialists, and Cardiologists.

This article has been reviewed by our medical advisory team, including endocrinologists, internal medicine specialists, and cardiologists, and is based on current scientific evidence and Indian clinical guidelines. Last reviewed: June 2026.

Sources

• RSSDI and ICMR clinical practice guidelines
• CDSCO regulatory advisories
• Peer-reviewed trials (NEJM, Lancet, JAMA, and others)
• Indian epidemiology on thin-fat phenotype and metabolic risk

What we do not do

• Prescribe or sell GLP-1 medications
• Promote specific pharmaceutical brands
• Claim patients qualify for treatment
• Provide personalised medical diagnosis

Updates

Articles display publication and last-reviewed dates. We update content when guidelines change, new CDSCO advisories are issued, or significant trial data emerges.